An observational study in COPD and Healthy Adult, sponsored by Groupe Hospitalier du Havre. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-28.
Sponsored by Groupe Hospitalier du Havre · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre — 3 open to participants now, 3 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Groupe Hospitalier du Havre.
Among the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre, this one is one of 2 that started in 2026, is one of 5 observational ones, and was the 9th registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →3 of the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre are open now, in 1 country. Recruiting first, the newest first:
Groupe Hospitalier du Havre · Sites in France
Ages 18+
Groupe Hospitalier du Havre · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 20 is below the median of 159 across 1,498 observational studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 22 across the 5 interventional studies, 30 across the 5 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Groupe Hospitalier du Havre is the lead sponsor of 22 studies on the registry; 6 are open to participants now.
1 of the studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07371754Groupe Hospitalier du HavreShear Wave Elastography of Intercostal Muscles for the Non-invasive Assessment of the Work of BreathinG | 2027-03-01 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Pulmonary Disease, Chronic Obstructive by Groupe Hospitalier du Havre, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Quantifying respiratory effort is a key step in physiological and clinical research on exercise tolerance, mechanisms of fatigability, and ventilatory impairment. To date, reliable assessment relies on an invasive method: esophageal pressure (Pes) measurement using a balloon catheter inserted into the esophagus. Although Pes provides an indirect estimate of pleural and intrathoracic pressure, it is uncomfortable for patients, requires dedicated equipment, and may limit study participation.
In critically ill patients, a noninvasive approach to quantify respiratory effort would have major clinical and scientific value. In acute respiratory distress, accurately tracking the intensity and evolution of respiratory effort could support earlier therapeutic decision-making.
Shear Wave Elastography (SWE) is an ultrasound technology enabling very high acquisition rates and estimating tissue stiffness from shear-wave propagation induced by an acoustic impulse. Because muscle stiffness is strongly related to force produced during contraction, we hypothesize that intercostal muscle stiffness measured by SWE correlates with respiratory work and increases with rising inspiratory load.
Adults (≥18 years) will be enrolled in two cohorts: (1) healthy adult volunteers and (2) adult patients with chronic obstructive pulmonary disease (COPD), stage 3-4. A total of 20 participants will be recruited (10 COPD patients and 10 healthy volunteers). Each participant will complete a single study visit (\~45 minutes) involving standardized breathing/inspiratory loading while intercostal muscle ultrasound shear wave elastography is recorded, with concurrent physiological reference measurements to quantify respiratory effort.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adult patient with (COPD), stage 3-4.
Healthy adult volunteer.
Exclusion Criteria:
Refusal to participate or withdrawal of consent.
Age \< 18 years.
> 35 kg/m².
Pregnancy or breastfeeding.
Inability to understand instructions or cooperate (cognitive impairment, language barrier).
Neurological condition affecting breathing (e.g., recent stroke, ALS, myopathy).
Thoracic condition limiting access to the intercostal muscles (e.g., major chest wall deformity, surgical scar).
Recent thoracic or abdominal surgery (\< 3 months).
Known esophageal disease (stricture, achalasia, severe esophagitis, diverticulum, history of perforation).
ENT or tracheal abnormality preventing probe insertion (e.g., tumor, malformation, tracheostomy).
Swallowing disorders or risk of aspiration.
Recent exacerbation (\< 6 weeks).
Oxygen therapy > 2 L/min during exertion.
Hemodynamic instability.
Not affiliated with a social security scheme.
Legally protected persons (as defined by law).
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participant without respiratory, muscle or thoracic abnormalities
Diagnostic Test: Intercostal muscle shear wave elastography (SWE) during standardized inspiratory loading
Patients with COPD
Diagnostic Test: Intercostal muscle shear wave elastography (SWE) during standardized inspiratory loading
Ultrasound shear wave elastography (SWE) is performed to quantify intercostal muscle stiffness at rest and during standardized inspiratory loading/controlled breathing. SWE acquisitions are synchronized with physiological reference recordings (e.g., esophageal pressure and/or diaphragm EMG when available) to estimate and track respiratory effort/work noninvasively.
Also known as: Ultrasound shear wave elastography of intercostal muscles
Correlation between intercostal muscle stiffness (SWE) and respiratory effort (esophageal pressure-time product)
Intercostal muscle stiffness (kPa) measured by shear wave elastography is correlated with respiratory effort quantified by the esophageal pressure-time product (PTPes; cmH2O·s/min) across the standardized inspiratory loading protocol (within each cohort).
Time frame: During a single study visit (≈45 minutes), at rest and at each standardized inspiratory load level
Within-subject change in intercostal muscle stiffness (SWE) across inspiratory load levels
Intercostal muscle stiffness (kPa) measured by shear wave elastography (SWE) will be assessed within participants across the different inspiratory load levels.
Time frame: Single study visit: during the inspiratory loading protocol (no resistance, then 25%, 50%, and 75% of maximal inspiratory pressure [PiMax])
No study locations are listed for this record.
Plan to share: Yes — Individual participant data (IPD) will be made available upon reasonable request. Requests will be reviewed on a case-by-case basis and, if approved, de-identified data and relevant documentation (e.g., protocol and data dictionary) will be shared under an appropriate data use agreement.
No publications or documents are linked to this record.
Start is estimated for Mar 2026; primary completion for Mar 2027, 12 months later.
Of 469 non-industry observational studies under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 62. This study's planned 12 months is below that.
Counting every sponsor, half of 589 studies reached it within 26 months; a quarter within 14 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Groupe Hospitalier du Havre